These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
405 related articles for article (PubMed ID: 37118810)
1. The interplay of cells, polymers, and vascularization in three-dimensional lung models and their applications in COVID-19 research and therapy. Ahmed TA; Eldaly B; Eldosuky S; Elkhenany H; El-Derby AM; Elshazly MF; El-Badri N Stem Cell Res Ther; 2023 Apr; 14(1):114. PubMed ID: 37118810 [TBL] [Abstract][Full Text] [Related]
2. Harnessing three-dimensional (3D) cell culture models for pulmonary infections: State of the art and future directions. Shah DD; Raghani NR; Chorawala MR; Singh S; Prajapati BG Naunyn Schmiedebergs Arch Pharmacol; 2023 Nov; 396(11):2861-2880. PubMed ID: 37266588 [TBL] [Abstract][Full Text] [Related]
4. Uniform sized cancer spheroids production using hydrogel-based droplet microfluidics: a review. Kim S; Lam PY; Jayaraman A; Han A Biomed Microdevices; 2024 May; 26(2):26. PubMed ID: 38806765 [TBL] [Abstract][Full Text] [Related]
5. Methodological aspects and pharmacological applications of three-dimensional cancer cell cultures and organoids. Foglietta F; Canaparo R; Muccioli G; Terreno E; Serpe L Life Sci; 2020 Aug; 254():117784. PubMed ID: 32416169 [TBL] [Abstract][Full Text] [Related]
6. Three-dimensional models of the lung: past, present and future: a mini review. Sen C; Freund D; Gomperts BN Biochem Soc Trans; 2022 Apr; 50(2):1045-1056. PubMed ID: 35411381 [TBL] [Abstract][Full Text] [Related]
8. Three-Dimensional Cell Cultures as a Research Platform in Lung Diseases and COVID-19. da Silva da Costa FA; Soares MR; Malagutti-Ferreira MJ; da Silva GR; Lívero FADR; Ribeiro-Paes JT Tissue Eng Regen Med; 2021 Oct; 18(5):735-745. PubMed ID: 34080133 [TBL] [Abstract][Full Text] [Related]
9. Probing prodrug metabolism and reciprocal toxicity with an integrated and humanized multi-tissue organ-on-a-chip platform. Rajan SAP; Aleman J; Wan M; Pourhabibi Zarandi N; Nzou G; Murphy S; Bishop CE; Sadri-Ardekani H; Shupe T; Atala A; Hall AR; Skardal A Acta Biomater; 2020 Apr; 106():124-135. PubMed ID: 32068138 [TBL] [Abstract][Full Text] [Related]
10. An Adverse Outcomes Approach to Study the Effects of SARS-CoV-2 in 3D Organoid Models. Basu A; Pamreddy A; Singh P; Sharma K J Mol Biol; 2022 Feb; 434(3):167213. PubMed ID: 34437890 [TBL] [Abstract][Full Text] [Related]
11. Modeling neoplastic disease with spheroids and organoids. Zanoni M; Cortesi M; Zamagni A; Arienti C; Pignatta S; Tesei A J Hematol Oncol; 2020 Jul; 13(1):97. PubMed ID: 32677979 [TBL] [Abstract][Full Text] [Related]
12. Three-dimensional lung tumor microenvironment modulates therapeutic compound responsiveness in vitro--implication for drug development. Ekert JE; Johnson K; Strake B; Pardinas J; Jarantow S; Perkinson R; Colter DC PLoS One; 2014; 9(3):e92248. PubMed ID: 24638075 [TBL] [Abstract][Full Text] [Related]
13. Stem cell-derived organoid models for SARS-CoV-2 and its molecular interaction with host cells. Dawoody Nejad L; Julian LM Mol Biol Rep; 2023 Dec; 50(12):10627-10635. PubMed ID: 37740859 [TBL] [Abstract][Full Text] [Related]
14. A Facile, Transfection-Free Approach to siRNA Delivery in In Vitro 3D Spheroid Models. Riching AS; Malloy A; Anderson EM; Sheard J; Mikkonen P; van Brabant Smith A; Strezoska Z; Levenga J Curr Protoc; 2024 Sep; 4(9):e1121. PubMed ID: 39225471 [TBL] [Abstract][Full Text] [Related]
15. Human iPS Cell-Derived Patient Tissues and 3D Cell Culture Part 2: Spheroids, Organoids, and Disease Modeling. Eglen RM; Reisine T SLAS Technol; 2019 Feb; 24(1):18-27. PubMed ID: 30798678 [TBL] [Abstract][Full Text] [Related]
16. In Vitro three-dimensional (3D) cell culture tools for spheroid and organoid models. Lee SY; Koo IS; Hwang HJ; Lee DW SLAS Discov; 2023 Jun; 28(4):119-137. PubMed ID: 36997090 [TBL] [Abstract][Full Text] [Related]
17. Preclinical Testing Techniques: Paving the Way for New Oncology Screening Approaches. van Rijt A; Stefanek E; Valente K Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760435 [TBL] [Abstract][Full Text] [Related]
18. Cost-effective 3D lung tissue spheroid as a model for SARS-CoV-2 infection and drug screening. Miranda GASC; Corrêa IA; Amorim ÉA; Caldas LA; Carneiro FÁ; da Costa LJ; Granjeiro JM; Tanuri A; de Souza W; Baptista LS Artif Organs; 2024 Jul; 48(7):723-733. PubMed ID: 38385713 [TBL] [Abstract][Full Text] [Related]
19. Using 3-Dimensional Cultures to Propagate Genetically Modified Lung Organoids. Chen F; Naughton KJ; Lee JH; Brainson CF Methods Mol Biol; 2024; 2805():19-30. PubMed ID: 39008172 [TBL] [Abstract][Full Text] [Related]
20. Insights on Three Dimensional Organoid Studies for Stem Cell Therapy in Regenerative Medicine. Mulaudzi PE; Abrahamse H; Crous A Stem Cell Rev Rep; 2024 Feb; 20(2):509-523. PubMed ID: 38095787 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]